Pharmaceutical firm launches new anti malaria drug formulation in Kenyan market
A Global Pharmaceutical firm on Friday launched a new anti malaria drug formulation into the Kenyan market that is aimed at increasing adherence to the medication.
"Malaria patients now only have to take one tablet per dose compared to the four tablets previously," Novartis Pharma Services Manager for Africa Operations Nathan Mulure said in Nairobi.
Novartis said that the new formulation has already been launched in Nigeria and.... Read more »
Posted on : Wednesday , 19th November 2014